Belite Bio, Inc
BLTE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | – | $0 | $0 | $31,677 |
| Short-Term Investments | – | $0 | $0 | $113,472 |
| Receivables | – | $0 | $0 | $594 |
| Inventory | – | $0 | $0 | $0 |
| Other Curr. Assets | – | $150,970 | $159,287 | $1,330 |
| Total Curr. Assets | – | $150,970 | $159,287 | $147,073 |
| Property Plant & Equip (Net) | – | $0 | $0 | $965 |
| Goodwill | – | $0 | $0 | $0 |
| Intangibles | – | $0 | $0 | $3,991 |
| Long-Term Investments | – | $0 | $0 | $0 |
| Tax Assets | – | $0 | $0 | $0 |
| Other NC Assets | – | $5,437 | $4,914 | $103 |
| Total NC Assets | – | $5,437 | $4,914 | $5,059 |
| Other Assets | – | $0 | $0 | $0 |
| Total Assets | – | $156,407 | $164,201 | $152,132 |
| Liabilities | – | – | – | – |
| Payables | – | $0 | $0 | $0 |
| Short-Term Debt | – | $0 | $0 | $276 |
| Tax Payable | – | $0 | $0 | $0 |
| Deferred Revenue | – | $0 | $0 | $0 |
| Other Curr. Liab. | – | $6,522 | $6,131 | $5,774 |
| Total Curr. Liab. | – | $6,522 | $6,131 | $6,050 |
| LT Debt | – | $0 | $0 | $261 |
| Deferred Rev, NC | – | $0 | $0 | $0 |
| Deferred Tax Liab, NC | – | $0 | $0 | $0 |
| Other NC Liab. | – | $0 | $0 | $0 |
| Total NC Liab. | – | $0 | $0 | $261 |
| Other Liabilities | – | $0 | $0 | $0 |
| Cap. Leases | – | $0 | $0 | $537 |
| Total Liabilities | – | $6,522 | $6,131 | $6,311 |
| Equity | – | – | – | – |
| Pref Stock | – | $0 | $0 | $0 |
| Common Stock | – | $149,885 | $158,070 | $3 |
| Retained Earnings | – | $0 | $0 | -$107,647 |
| AOCI | – | $0 | $0 | -$660 |
| Other Equity | – | $0 | $0 | $254,125 |
| Total Equity | – | $149,885 | $158,070 | $145,821 |
| Supplemental Information | – | – | – | – |
| Minority Interest | – | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | – | $156,407 | $164,201 | $152,132 |
| Net Debt | $0 | $0 | $0 | -$31,140 |